Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria
Authors:
Open Access
- 29 December 2015
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 30 (5) , 1126-1132
Abstract
Essential thrombocythemia (ET) is currently diagnosed either by the British Committee of Standards in Haematology (BCSH) criteria that are predominantly based on exclusion and not necessarily on bone marrow (BM) morphology, or the World Health Organization (WHO) criteria that require BM examination as essential criterion. We studied the morphological and clinical features in patients diagnosed according either to the BCSH (n=238) or the WHO guidelines (n=232). The BCSH-defined ET cohort was re-evaluated by applying the WHO classification. At presentation patients of the BCSH group showed significantly higher values of serum lactate dehydrogenase and had palpable splenomegaly more frequently. Following the WHO criteria, the re-evaluation of the BCSH-diagnosed ET cohort displayed a heterogeneous population with 141 (59.2%) ET, 77 (32.4%) prefibrotic primary myelofibrosis (prePMF), 16 (6.7%) polycythemia vera, and 4 (1.7%) primary myelofibrosis. Contrasting WHO-confirmed ET, the BCSH cohort revealed a significant worsening of fibrosis-free survival and prognosis. As demonstrated by the clinical data and different outcomes between WHO-diagnosed ET and prePMF, these adverse features were generated by the inadvertent inclusion of prePMF to the BCSH group. Taken together, the diagnosis of ET without a scrutinized examination of BM biopsy specimens will generate a heterogeneous cohort of patients impairing an appropriate clinical management.Keywords
This publication has 48 references indexed in Scilit:
- Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosisBlood, 2008
- Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypesBlood, 2008
- Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibresBritish Journal of Haematology, 2007
- Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatmentLeukemia, 2007
- Amendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosisBritish Journal of Haematology, 2007
- The Impact of Clinicopathological Studies on Staging and Survival in Essential Thrombocythemia, Chronic Idiopathic Myelofibrosis, and Polycythemia Rubra VeraSeminars in Thrombosis and Hemostasis, 2006
- Clinicopathological Criteria for Differential Diagnosis of Thrombocythemias in Various Myeloproliferative DisordersSeminars in Thrombosis and Hemostasis, 2006
- Grade of bone marrow fibrosis is associated with relevant hematological findings—a clinicopathological study on 865 patients with chronic idiopathic myelofibrosisAnnals of Hematology, 2006
- Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoieticbone marrow histologyLeukemia & Lymphoma, 2006
- Hematopathologic Findings in Chronic Idiopathic MyelofibrosisSeminars in Oncology, 2005